| 标题 |
Risk-benefit stratification for immune checkpoint inhibitor therapy in head and neck cancer based on immune-related adverse events and treatment discontinuation using routine clinical indicators beyond PD-L1 expression |
| 网址 | |
| DOI | |
| 其它 |
期刊:Oral Oncol 作者:Kasahara K, Kono T, Sato Y, Okubo K, Shigetomi S, Sasaki A, Hentona K, Mokudai Y, Oguchi K, Izawa M, Shinden S, Ozawa H 出版日期:2026-03-19 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)